At a glance
- Originator Merck KGaA
- Class Opioid analgesics; Small molecules
- Mechanism of Action Opioid kappa receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 20 Jan 1995 Discontinued-Preclinical for Pain in Germany (Unknown route)